CN102186820B - Rassf1a表达和人癌细胞增殖的荧光调节剂 - Google Patents
Rassf1a表达和人癌细胞增殖的荧光调节剂 Download PDFInfo
- Publication number
- CN102186820B CN102186820B CN2009801406819A CN200980140681A CN102186820B CN 102186820 B CN102186820 B CN 102186820B CN 2009801406819 A CN2009801406819 A CN 2009801406819A CN 200980140681 A CN200980140681 A CN 200980140681A CN 102186820 B CN102186820 B CN 102186820B
- Authority
- CN
- China
- Prior art keywords
- rassf1a
- cancer
- cells
- cell
- compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/56—Ring systems containing three or more rings
- C07D209/80—[b, c]- or [b, d]-condensed
- C07D209/82—Carbazoles; Hydrogenated carbazoles
- C07D209/88—Carbazoles; Hydrogenated carbazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the ring system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Indole Compounds (AREA)
- Electroluminescent Light Sources (AREA)
- Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US18905908P | 2008-08-15 | 2008-08-15 | |
| US61/189,059 | 2008-08-15 | ||
| PCT/US2009/004681 WO2010019271A1 (en) | 2008-08-15 | 2009-08-14 | Fluorescent regulators of rassf1a expression and human cancer cell proliferation |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN102186820A CN102186820A (zh) | 2011-09-14 |
| CN102186820B true CN102186820B (zh) | 2013-08-28 |
Family
ID=41279343
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2009801406819A Expired - Fee Related CN102186820B (zh) | 2008-08-15 | 2009-08-14 | Rassf1a表达和人癌细胞增殖的荧光调节剂 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US10457639B2 (cg-RX-API-DMAC7.html) |
| EP (2) | EP2323982B1 (cg-RX-API-DMAC7.html) |
| JP (2) | JP2012500197A (cg-RX-API-DMAC7.html) |
| CN (1) | CN102186820B (cg-RX-API-DMAC7.html) |
| AT (1) | ATE547403T1 (cg-RX-API-DMAC7.html) |
| AU (1) | AU2009282451B2 (cg-RX-API-DMAC7.html) |
| BR (1) | BRPI0917411A2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2734225A1 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2010019271A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (34)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8097712B2 (en) | 2007-11-07 | 2012-01-17 | Beelogics Inc. | Compositions for conferring tolerance to viral disease in social insects, and the use thereof |
| US8962584B2 (en) | 2009-10-14 | 2015-02-24 | Yissum Research Development Company Of The Hebrew University Of Jerusalem, Ltd. | Compositions for controlling Varroa mites in bees |
| KR101982126B1 (ko) | 2010-03-08 | 2019-05-27 | 몬산토 테크놀로지 엘엘씨 | 식물에서 유전자 조절을 위한 폴리뉴클레오타이드 분자 |
| US8637679B2 (en) | 2011-03-11 | 2014-01-28 | Council Of Scientific And Industrial Research | Process for the isolation of organic compounds useful for the treatment of cancer |
| EP3434780A1 (en) | 2011-09-13 | 2019-01-30 | Monsanto Technology LLC | Methods and compositions for weed control |
| BR112014005975A8 (pt) | 2011-09-13 | 2017-09-12 | Monsanto Technology Llc | Método de controle de planta, método de redução de expressão de um gene pds em uma planta, cassete de expressão microbiana, método de fazer um polinucleotídeo, método de identificação de polinucleotídeos, e composições para controle de erva daninha |
| AU2012308660B2 (en) | 2011-09-13 | 2017-05-25 | Monsanto Technology Llc | Methods and compositions for weed control |
| CA2848685A1 (en) | 2011-09-13 | 2013-03-21 | Monsanto Technology Llc | Methods and compositions for weed control comprising topical application of a glutamine synthetase polynucleotide |
| US10760086B2 (en) | 2011-09-13 | 2020-09-01 | Monsanto Technology Llc | Methods and compositions for weed control |
| US10829828B2 (en) | 2011-09-13 | 2020-11-10 | Monsanto Technology Llc | Methods and compositions for weed control |
| US10806146B2 (en) | 2011-09-13 | 2020-10-20 | Monsanto Technology Llc | Methods and compositions for weed control |
| BR112014005958A2 (pt) | 2011-09-13 | 2020-10-13 | Monsanto Technology Llc | métodos e composições químicas agrícolas para controle de planta, método de redução de expressão de um gene accase em uma planta, cassete de expressão microbiana, método para fazer um polinucleotídeo, método de identificação de polinucleotídeos úteis na modulação de expressão do gene accase e composição herbicida |
| CN104619843B (zh) | 2012-05-24 | 2020-03-06 | A.B.种子有限公司 | 用于使基因表达沉默的组合物和方法 |
| UY35251A (es) | 2013-01-01 | 2014-07-31 | Seeds Ltd Ab | MOLÉCULAS DE dsRNA AISLADAS Y MÉTODOS PARA USARLAS PARA SILENCIAR MOLÉCULAS DIANA DE INTERÉS |
| US10683505B2 (en) | 2013-01-01 | 2020-06-16 | Monsanto Technology Llc | Methods of introducing dsRNA to plant seeds for modulating gene expression |
| AU2014248958A1 (en) | 2013-03-13 | 2015-10-01 | Monsanto Technology Llc | Methods and compositions for weed control |
| CA2905027A1 (en) | 2013-03-13 | 2014-10-09 | Monsanto Technology Llc | Methods and compositions for weed control |
| US20160015743A1 (en) * | 2013-03-15 | 2016-01-21 | Rush University Medical Center | Methods for treating cancer |
| US10568328B2 (en) | 2013-03-15 | 2020-02-25 | Monsanto Technology Llc | Methods and compositions for weed control |
| MX359191B (es) | 2013-07-19 | 2018-09-18 | Monsanto Technology Llc | Composiciones y métodos para controlar leptinotarsa. |
| US9850496B2 (en) | 2013-07-19 | 2017-12-26 | Monsanto Technology Llc | Compositions and methods for controlling Leptinotarsa |
| AR098295A1 (es) | 2013-11-04 | 2016-05-26 | Monsanto Technology Llc | Composiciones y métodos para controlar infestaciones de plagas y parásitos de los artrópodos |
| UA119253C2 (uk) | 2013-12-10 | 2019-05-27 | Біолоджикс, Інк. | Спосіб боротьби із вірусом у кліща varroa та у бджіл |
| AU2015206585A1 (en) | 2014-01-15 | 2016-07-21 | Monsanto Technology Llc | Methods and compositions for weed control using EPSPS polynucleotides |
| EP3420809A1 (en) | 2014-04-01 | 2019-01-02 | Monsanto Technology LLC | Compositions and methods for controlling insect pests |
| US10988764B2 (en) | 2014-06-23 | 2021-04-27 | Monsanto Technology Llc | Compositions and methods for regulating gene expression via RNA interference |
| EP3161138A4 (en) | 2014-06-25 | 2017-12-06 | Monsanto Technology LLC | Methods and compositions for delivering nucleic acids to plant cells and regulating gene expression |
| CN114009454A (zh) | 2014-07-29 | 2022-02-08 | 孟山都技术公司 | 用于控制昆虫害虫的组合物和方法 |
| RU2723049C2 (ru) | 2015-01-22 | 2020-06-08 | Монсанто Текнолоджи Ллс | Композиции и способы борьбы с leptinotarsa |
| US10883103B2 (en) | 2015-06-02 | 2021-01-05 | Monsanto Technology Llc | Compositions and methods for delivery of a polynucleotide into a plant |
| US10655136B2 (en) | 2015-06-03 | 2020-05-19 | Monsanto Technology Llc | Methods and compositions for introducing nucleic acids into plants |
| US10173978B2 (en) | 2015-08-05 | 2019-01-08 | Georgetown University | Small molecule androgen receptor inhibitors and methods of use thereof |
| JP7236382B2 (ja) * | 2017-06-12 | 2023-03-09 | 昇平 宮田 | 抗癌剤及びその使用 |
| CN107266356B (zh) * | 2017-07-25 | 2020-06-26 | 山西省生物研究院有限公司 | 一种作为自分泌运动因子抑制剂的咔唑类化合物及其制备方法和应用 |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2008051523A2 (en) * | 2006-10-23 | 2008-05-02 | Georgetown University | Carbazole derivatives useful as medicaments in cancer therapy |
Family Cites Families (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2235815A1 (de) * | 1972-07-21 | 1974-01-31 | Bayer Ag | Polyazofarbstoffe |
| US4925673A (en) | 1986-08-18 | 1990-05-15 | Clinical Technologies Associates, Inc. | Delivery systems for pharmacological agents encapsulated with proteinoids |
| US5013556A (en) | 1989-10-20 | 1991-05-07 | Liposome Technology, Inc. | Liposomes with enhanced circulation time |
| JP3507486B2 (ja) | 1991-03-15 | 2004-03-15 | アムジエン・インコーポレーテツド | 顆粒球コロニー刺激因子の肺内投与 |
| GB9215361D0 (en) | 1992-07-20 | 1992-09-02 | Wellcome Found | Heterocyclic compounds |
| JP3690825B2 (ja) * | 1993-07-26 | 2005-08-31 | エーザイ株式会社 | 三環式ヘテロ環含有スルホンアミドおよびスルホン酸エステル誘導体 |
| DE69431470T2 (de) * | 1993-07-26 | 2003-08-14 | Eisai Co., Ltd. | Sulfonamide und sulfonsäure-ester mit je einem trizyclischen heteroring |
| CA2186412A1 (en) | 1995-10-31 | 1997-05-01 | Katherine S. Takaki | Ethylamino carbazole melatonergic agents |
| DE69830513T2 (de) | 1997-12-22 | 2006-03-16 | Bayer Pharmaceuticals Corp., West Haven | HEMMUNG DER p38 KINASE UNTER VERWENDUNG VON SYMMETRISCHEN UND ASYMMETRISCHEN DIPHENYLHARNSTOFFEN |
| US6713473B1 (en) | 1999-04-20 | 2004-03-30 | Meiji Seika Kaisha, Ltd. | Tricyclic compounds |
| EP1238973A4 (en) | 1999-12-16 | 2003-01-22 | Asahi Chemical Ind | NEW SUBSTITUTED TRICYCLIC COMPOUNDS |
| AU2001252575A1 (en) | 2000-04-28 | 2001-11-12 | Asahi Kasei Kabushiki Kaisha | Novel tricyclic compounds |
| US6506901B2 (en) * | 2000-07-17 | 2003-01-14 | Wyeth | Substituted 2-(S)-hydroxy-3-(piperidin-4-yl-methylamino)-propyl ethers and substituted 2-aryl-2-(R)-hydroxy-1-(piperidin-4-yl-methyl)-ethylamine β-3 adrenergic receptor agonists |
| WO2002049632A1 (en) | 2000-12-18 | 2002-06-27 | Institute Of Medicinal Molecular Design. Inc. | Inhibitors against the production and release of inflammatory cytokines |
| AU2002228316A1 (en) * | 2001-01-29 | 2002-08-12 | Insight Strategy And Marketing Ltd | Carbazole derivatives and their uses as heparanase inhibitors |
| WO2002074306A1 (en) | 2001-03-19 | 2002-09-26 | Asahi Kasei Kabushiki Kaisha | Remedies for fatty liver |
| GB0319151D0 (en) * | 2003-08-14 | 2003-09-17 | Glaxo Group Ltd | Novel compounds |
| US20100063126A1 (en) | 2004-06-29 | 2010-03-11 | Jadolabs Gmbh | Carbazole-Derived Pharmaceutical Compositions |
| WO2006018405A1 (en) | 2004-08-18 | 2006-02-23 | Ciba Specialty Chemicals Holding Inc. | Oxime ester photoinitiators |
| ITMI20051523A1 (it) * | 2005-08-03 | 2007-02-04 | Acraf | Composto del 3-ammino-carbazolo composizione farmaceutica che lo contiene e metodo per prepararlo |
| GB2443588B (en) | 2005-09-01 | 2010-04-21 | Council Scient Ind Res | A pharmaceutical composition useful for the treatment of prostate cancer |
| CN1807413B (zh) | 2005-09-28 | 2010-05-05 | 中国医学科学院医药生物技术研究所 | 咔唑磺酰胺衍生物及其制备方法 |
| BRPI0617364A2 (pt) * | 2005-10-13 | 2011-07-26 | Orchid Res Lab Ltd | compostos heterocÍclicos como inibidores de pstat3/il-6 |
| IL186935A0 (en) | 2006-10-31 | 2008-02-09 | Veridex Llc | Prostate cancer field effect analysis methods and kits |
| AU2008345036A1 (en) | 2007-12-28 | 2009-07-09 | John Wayne Cancer Institute | Use of methylation status of MINT loci and tumor-related genes as a marker for melanoma and breast cancer |
| ES2524259T3 (es) | 2008-03-24 | 2014-12-04 | Novartis Ag | Inhibidores de metaloproteinasa de matriz a base de arilsulfonamida |
-
2009
- 2009-08-14 EP EP09789145A patent/EP2323982B1/en not_active Not-in-force
- 2009-08-14 BR BRPI0917411A patent/BRPI0917411A2/pt not_active IP Right Cessation
- 2009-08-14 CA CA2734225A patent/CA2734225A1/en not_active Abandoned
- 2009-08-14 AU AU2009282451A patent/AU2009282451B2/en not_active Ceased
- 2009-08-14 WO PCT/US2009/004681 patent/WO2010019271A1/en not_active Ceased
- 2009-08-14 JP JP2011523005A patent/JP2012500197A/ja active Pending
- 2009-08-14 CN CN2009801406819A patent/CN102186820B/zh not_active Expired - Fee Related
- 2009-08-14 US US13/059,183 patent/US10457639B2/en active Active
- 2009-08-14 AT AT09789145T patent/ATE547403T1/de active
- 2009-08-14 EP EP20120152000 patent/EP2484666A1/en not_active Withdrawn
-
2014
- 2014-05-21 JP JP2014105150A patent/JP2014148545A/ja active Pending
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2008051523A2 (en) * | 2006-10-23 | 2008-05-02 | Georgetown University | Carbazole derivatives useful as medicaments in cancer therapy |
Also Published As
| Publication number | Publication date |
|---|---|
| AU2009282451A1 (en) | 2010-02-18 |
| JP2012500197A (ja) | 2012-01-05 |
| US10457639B2 (en) | 2019-10-29 |
| WO2010019271A1 (en) | 2010-02-18 |
| US20110152339A1 (en) | 2011-06-23 |
| BRPI0917411A2 (pt) | 2015-12-01 |
| EP2323982A1 (en) | 2011-05-25 |
| CN102186820A (zh) | 2011-09-14 |
| JP2014148545A (ja) | 2014-08-21 |
| WO2010019271A8 (en) | 2011-03-31 |
| AU2009282451B2 (en) | 2014-02-13 |
| ATE547403T1 (de) | 2012-03-15 |
| CA2734225A1 (en) | 2010-02-18 |
| EP2323982B1 (en) | 2012-02-29 |
| HK1158206A1 (en) | 2012-07-13 |
| EP2484666A1 (en) | 2012-08-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP2323982B1 (en) | Fluorescent regulators of rassf1a expression and human cancer cell proliferation | |
| JP4989976B2 (ja) | 翻訳開始阻害剤としての3−3−二置換オキシインドール | |
| CN101360422B (zh) | 致癌Ras特异性细胞毒化合物及其使用方法 | |
| US9132102B2 (en) | Stilbene analogs and methods of treating cancer | |
| CA2953079C (en) | Intermittent dosing of mdm2 inhibitor | |
| JP2020513789A (ja) | ヘテロ二官能性化合物を用いた調整可能な内因性タンパク質分解 | |
| JP2014012706A (ja) | 抗がん活性を有する化合物 | |
| US20100130579A1 (en) | Cancer therapy | |
| US20100028348A1 (en) | Compositions and Methods for Inhibiting an Isoform of Human Manganese Superoxide Dismutase | |
| FR2921927A1 (fr) | Imidazo[1,2-a]quinoxalines et derives pour le traitement des cancers | |
| JP2014531402A5 (cg-RX-API-DMAC7.html) | ||
| JP2014531402A (ja) | 新規アニリン誘導体及びこれの用途(Novelanilinederivativesandusethereof) | |
| AU2015314772A1 (en) | Compositions and methods for treatment of prostate carcinoma | |
| JP2005516938A (ja) | イソインジゴ、インジゴおよびインジルビンの誘導体、ならびに癌治療における使用 | |
| JP2013518906A (ja) | 複製タンパク質aを阻害する物質および方法ならびにその使用 | |
| US10450295B2 (en) | Method of using an indolinone molecule and derivatives for inhibiting liver fibrosis and hepatitis | |
| AU2015225828B2 (en) | Mcl-1 modulating compounds for cancer treatment | |
| AU2014202507B2 (en) | Fluorescent regulators of RASSF1A expression and human cancer cell proliferation | |
| US9175001B2 (en) | [1,3] dioxolo [4,5-g] [1,2,4] triazolo [1,5-a] quinoline derivatives as inhibitors of the late SV40 factor (LSF) for use in treating cancer | |
| HK1158206B (en) | Fluorescent regulators of rassf1a expression and human cancer cell proliferation | |
| WO2019022556A1 (ko) | 신규한 벤질리덴아세톤 유도체 및 이의 용도 | |
| WO2013121385A1 (fr) | Utilisation de dérivés de carbazolophénone pour le traitement du cancer | |
| WO2018076537A1 (zh) | D-3-磷酸甘油酸脱氢酶别构抑制剂及其应用 | |
| FR3126982A1 (fr) | Vecteurs ciblant la beta-d-n-acetylglucosaminidase | |
| TWI415611B (zh) | 喹啉衍生物及其應用 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20130828 Termination date: 20180814 |